IL17A and neoplasm: This may result from the interaction of ob-ASC with AT-infiltrating immune cells, which leads to the activation of pathogenic Th17 cells double secreting IL-17 and IFNγ and able to increase pro-inflammatory cytokine and neo-angiogenic factor secretion in tumor cells and stimulate ICP over-expression.